查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1878892

臨床診斷市場－全球產業規模、佔有率、趨勢、機會和預測，按檢測項目、產品、最終用戶、地區和競爭格局分類，2020-2030年預測

Clinical Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test, By Product, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 189 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球臨床診斷市場規模為822.2億美元，預計2030年將以6.45%的複合年成長率成長至1196.5億美元。全球臨床診斷市場涵蓋對生物樣本進行的各種實驗室檢測，用於疾病的檢測、診斷、監測和指導治療。其成長的主要促進因素包括全球慢性病和傳染病患者病率的上升、人口老化加劇以及人們對預防性醫療保健和疾病早期檢測意識的提高。

市場概覽
預測期 2026-2030
2024年市場規模 822.2億美元
2030年市場規模 1196.5億美元
2025-2030年複合年成長率 6.45%
成長最快的細分市場 全血球計數
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球臨床診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依檢測項目分類（血脂檢查、肝功能檢查、腎功能檢查、全血球計數、電解質檢查、傳染病檢查、其他檢測項目）
    • 依產品分類（儀器、試劑、其他產品）
    • 依最終用戶分類（醫院實驗室、診斷實驗室、即時檢測、其他最終用戶）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美臨床診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲臨床診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區臨床診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲臨床診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲臨床診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球臨床診斷市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Abbott Laboratories, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Siemens Healthineers AG
  • Hologic Inc.
  • Qiagen NV
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Quest Diagnostics, Inc.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 4519

The Global Clinical Diagnostics Market , valued at USD 82.22 Billion in 2024, is projected to experience a CAGR of 6.45% to reach USD 119.65 Billion by 2030. The global clinical diagnostics market encompasses a wide array of laboratory tests performed on biological samples to detect, diagnose, monitor, and guide the management of diseases. Its growth is primarily driven by the increasing worldwide prevalence of chronic and infectious diseases, an expanding aging population, and heightened awareness concerning preventative healthcare and early disease detection.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 82.22 Billion
Market Size 2030USD 119.65 Billion
CAGR 2025-20306.45%
Fastest Growing SegmentComplete Blood Count
Largest MarketNorth America

Key Market Drivers

The increasing prevalence of chronic and infectious diseases constitutes a primary driver for the global clinical diagnostics market. The growing burden of conditions like diabetes, cardiovascular diseases, and various respiratory and other infections necessitates consistent, accurate diagnostic testing for effective disease management, early detection, and public health surveillance. These health challenges generate continuous demand for both routine and specialized diagnostic panels, enabling providers to identify diseases at treatable stages and monitor therapy. For instance, according to the CDC, in November 2024, "2023-2024 Influenza Season Summary: Influenza Severity Assessment, Burden and Burden Prevented", influenza was associated with 40 million illnesses in the United States during the 2023-2024 season, highlighting a significant need for diagnostic tools. This persistent demand underpins the market's growth trajectory.

Key Market Challenges

The complex and evolving global regulatory landscape represents a significant impediment to the growth of the Global Clinical Diagnostics Market. Stringent and often divergent requirements for product approval and market access across various jurisdictions directly contribute to extended development timelines and elevated operational expenditures for manufacturers and innovators. This regulatory burden diverts substantial resources that could otherwise be allocated to research and development or market expansion activities.

For instance, according to MedTech Europe's 2024 Regulatory Survey, certification and maintenance costs for in vitro diagnostic (IVD) devices under new European regulations escalated by 100% or more compared to previous directives. This significant increase directly impacts profitability and the ability of companies to invest in new diagnostic technologies.

Key Market Trends

The decentralization of testing through point-of-care diagnostics significantly influences the market by enabling rapid results and improving patient access outside traditional laboratory settings. This shift supports immediate clinical decision-making across various healthcare environments. A July 2024 Eurostat report indicated that 35.0% of EU residents reported having a chronic health problem in 2023, underscoring the ongoing need for accessible diagnostic tools. This expansion is exemplified by Siemens Healthineers partnering with Carna Health in August 2025 to introduce point-of-care chronic kidney disease testing in emerging markets, integrating an AI-derived platform with existing diagnostics infrastructure for improved early detection. This trend drives demand for portable, user-friendly diagnostic devices.

Key Market Players

  • Abbott Laboratories, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Siemens Healthineers AG
  • Hologic Inc.
  • Qiagen NV
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific, Inc.
  • Quest Diagnostics, Inc.

Report Scope:

In this report, the Global Clinical Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Clinical Diagnostics Market , By Test:

  • Lipid Panel
  • Liver Panel
  • Renal Panel
  • Complete Blood Count
  • Electrolyte Testing
  • Infectious Disease Testing
  • Other Tests

Clinical Diagnostics Market , By Product:

  • Instruments
  • Reagents
  • Other Products

Clinical Diagnostics Market , By End User:

  • Hospital Laboratory
  • Diagnostic Laboratory
  • Point-of-care Testing
  • Other End Users

Clinical Diagnostics Market , By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Clinical Diagnostics Market .

Available Customizations:

Global Clinical Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Clinical Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Test (Lipid Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, Other Tests)
    • 5.2.2. By Product (Instruments, Reagents, Other Products)
    • 5.2.3. By End User (Hospital Laboratory, Diagnostic Laboratory, Point-of-care Testing, Other End Users)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Clinical Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Test
    • 6.2.2. By Product
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Clinical Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Test
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Clinical Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Test
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Clinical Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Test
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By End User

7. Europe Clinical Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Test
    • 7.2.2. By Product
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Clinical Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Test
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By End User
    • 7.3.2. France Clinical Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Test
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Clinical Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Test
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Clinical Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Test
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Clinical Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Test
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By End User

8. Asia Pacific Clinical Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Test
    • 8.2.2. By Product
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Clinical Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Test
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By End User
    • 8.3.2. India Clinical Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Test
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Clinical Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Test
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Clinical Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Test
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Clinical Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Test
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By End User

9. Middle East & Africa Clinical Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Test
    • 9.2.2. By Product
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Clinical Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Test
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Clinical Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Test
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Clinical Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Test
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By End User

10. South America Clinical Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Test
    • 10.2.2. By Product
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Clinical Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Test
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Clinical Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Test
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Clinical Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Test
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Clinical Diagnostics Market : SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Becton, Dickinson and Company
  • 15.3. Bio-Rad Laboratories, Inc.
  • 15.4. Danaher Corporation
  • 15.5. Siemens Healthineers AG
  • 15.6. Hologic Inc.
  • 15.7. Qiagen NV
  • 15.8. F. Hoffmann-La Roche Ltd.
  • 15.9. Thermo Fisher Scientific, Inc.
  • 15.10. Quest Diagnostics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer